跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 50,003 条关于
“GRI Bio, Inc.”
全部
50,003
临床试验
17,584
药物
3,116
机构
6,380
资讯
22,923
3个月前
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
去年
GRI Bio Advances Phase 2a Trial of GRI-0621 for Idiopathic Pulmonary Fibrosis with Promising Interim Safety Data
7个月前
GRI Bio Secures Patent Protection for Novel NKT Cell-Targeting Compounds Across Inflammatory Diseases
9个月前
GRI Bio's GRI-0621 Shows Promise in Phase 2a IPF Trial with Disease-Modifying Potential
去年
INmune Bio's XPro Shows Promise in Alzheimer's, Faces Financial Hurdles
去年
OmniScience and INmune Bio Partner to Accelerate Alzheimer's Clinical Trial with AI
去年
Annovis Bio's Buntanetap Shows Promise in Neurodegenerative Disease Treatment
2年前
INmune Bio Announces $12 Million Offering to Advance Clinical Programs
去年
INmune Bio Completes Enrollment in Phase 2 Alzheimer's Trial Targeting Neuroinflammation
去年
INmune Bio's XPro™ Promotes Remyelination in Animal Models, Showing Promise for Alzheimer's Treatment
第 1 页,共 2293 页
上一页
下一页